Skip to content

An Exploratory Study on the Syndrome Differentiation and Treatment Principles of Traditional Chinese Medicine for Lung Cancer Complicated with Cough and Dyspnea, and the Exploration of Efficacy-Enhancing and Toxicity-Reducing Regimens-Part one

An Exploratory Study on the Syndrome Differentiation and Treatment Principles of Traditional Chinese Medicine for Lung Cancer Complicated with Cough and Dyspnea, and the Exploration of Efficacy-Enhancing and Toxicity-Reducing Regimens

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002586
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-03
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Study Cohort: standard antineoplastic therapy

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Meet the TCM diagnostic criteria for cough and dyspnea. 2.Fulfill the NSCLC diagnostic criteria outlined in the Chinese Medical Association's Clinical Guidelines for Lung Cancer Diagnosis and Treatment (2024 Edition). 3.Aged 40 years or older. 4.With an ECOG performance status score of 0 to 2. 5.Voluntarily participate in the study, provide signed informed consent, and demonstrate good compliance with the investigation.

Exclusion criteria

Exclusion criteria: 1.Pathologically confirmed mixed small cell carcinoma component. 2.Expected survival time of less than 3 months. 3.History of other malignant tumors. 4.Cough and dyspnea caused by other factors such as infection or other systemic diseases. 5.Diseases with known etiology or specific pathological manifestations causing airflow obstruction, such as cystic fibrosis or diffuse panbronchiolitis. 6.History of immunodeficiency, other congenital immunodeficiency disorders, or history of organ transplantation. 7.Presence of severe comorbid conditions that jeopardize patient safety or affect study completion. 8.Patients with other infectious diseases. 9.Patients with primary diseases or severe dysfunction of other vital organs (e.g., heart, liver, kidney). 10.Patients with severe neurotic disorders or mental illnesses. 11.Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine syndrome elements;

Secondary

MeasureTime frame
Diagnostic information from the four Traditional Chinese Medicine examinations;

Countries

China

Contacts

Public ContactLu Zhenhui

Longhua Hospital Shanghai University of Traditional Chinese Medicine

Dr_luzh@shutcm.edu.cn13817729859

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026